Certara, Inc.
$6.19
▼
-1.64%
2026-04-21 05:59:00
www.certara.com
NMS: CERT
Explore Certara, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$989.85 M
Current Price
$6.19
52W High / Low
$15.38 / $5.19
Stock P/E
—
Book Value
$6.68
Dividend Yield
—
ROCE
1.5%
ROE
-0.15%
Face Value
—
EPS
$-0.01
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
1,515
Beta
1.62
Debt / Equity
28.96
Current Ratio
2.05
Quick Ratio
2.05
Forward P/E
11.13
Price / Sales
2.11
Enterprise Value
$1 B
EV / EBITDA
10.17
EV / Revenue
2.39
Rating
Buy
Target Price
$8.99
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Zhongchao Inc. | $2.06 | — | $7.52 M | — | -1.4% | -24.88% | $12.18 / $1.44 | $6.39 |
| 2. | Teladoc Health, Inc. | $6.1 | — | $1.09 B | — | -6.66% | -13.93% | $9.77 / $4.4 | $7.77 |
| 3. | LifeMD, Inc. | $5.06 | 15.69 | $242.75 M | 1.28% | -26.6% | -1.31% | $15.84 / $2.56 | $0.5 |
| 4. | GoodRx Holdings, Inc. | $2.37 | 26.67 | $811.9 M | — | 7.56% | 4.54% | $5.81 / $1.77 | $1.81 |
| 5. | Hinge Health, Inc. | $43.93 | — | $3.41 B | — | -142.9% | -1.33% | $62.18 / $30.08 | $2.26 |
| 6. | CareCloud, Inc. | $3.2 | 12.59 | $135.98 M | 4.63% | 18.2% | 19.76% | $4.01 / $1.33 | $1.4 |
| 7. | Forian Inc. | $2.16 | — | $67.1 M | — | -8.29% | -9.61% | $2.71 / $1.64 | $0.96 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 103.65 M | 104.62 M | 104.57 M | 106 M | 100.36 M | — |
| Operating Profit | 0.84 M | 3 M | 9.55 M | 7.62 M | 6 M | — |
| Net Profit | -5.89 M | 1.52 M | -1.97 M | 4.74 M | 6.58 M | — |
| EPS in Rs | -0.04 | 0.01 | -0.01 | 0.03 | 0.04 | -0.01 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 418.84 M | 385.15 M | 354.34 M | 335.64 M |
| Operating Profit | 21.02 M | -1.73 M | 6.21 M | 32.52 M |
| Net Profit | -1.59 M | -12.05 M | -55.36 M | 14.73 M |
| EPS in Rs | -0.01 | -0.08 | -0.36 | 0.1 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.56 B | 1.58 B | 1.56 B | 1.57 B |
| Total Liabilities | 493.79 M | 516.45 M | 516.3 M | 493.26 M |
| Equity | 1.06 B | 1.06 B | 1.05 B | 1.08 B |
| Current Assets | 315.12 M | 310.85 M | 340.2 M | 342.25 M |
| Current Liabilities | 153.38 M | 146.09 M | 130.02 M | 103.16 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 96.33 M | 80.47 M | 82.75 M | 92.54 M |
| Investing CF | -26.56 M | -112.37 M | -79.55 M | -27.84 M |
| Financing CF | -63.99 M | -21.01 M | -9.45 M | -7.36 M |
| Free CF | 69.77 M | 59.42 M | 67.43 M | 80.01 M |
| Capex | -26.56 M | -21.04 M | -15.32 M | -12.53 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 8.7% | 5.57% | — | — |
| Earnings Growth % | 78.23% | -475.79% | — | — |
| Profit Margin % | -3.13% | -15.62% | 4.39% | — |
| Operating Margin % | -0.45% | 1.75% | 9.69% | — |
| Gross Margin % | 59.88% | 60.2% | 60.5% | — |
| EBITDA Margin % | 18.79% | 6.73% | 26.52% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.